BioMotiv
Accelerating Breakthrough Discoveries into Medicines

News

News

Oncology Start-up Dual Therapeutics Receives Investment from the Partnership Fund for New York City

NEW YORK CITY AND CLEVELAND, May 2, 2014

Dual Therapeutics, an oncology start-up developing therapeutics for prostate cancer, lung cancer, and acute lymphoblastic leukemia, with headquarters at Harlem Biospace, today announced an investment from the Partnership Fund for New York City.

Click here to read more